Home » Newsletters » BioWorld Asia

BioWorld Asia

April 11, 2001

View Archived Issues

Diversys Enters $10M Alliance, Secures $10M In Private Funding

MediGene Gains European Rights To Atrix's Leuprogel Product Line

DrugAbuse Completes $24M Financing To Advance Pipeline

Cardion Acquires Tolerance For Immunotherapy Platform

Merck Applies Crucell's Vector In Phase I HIV Vaccine Study

Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial

ExonHit, Institut Curie Align In Cancer Pharmacogenomics

UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests

Other News To Note

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.